cropped-Photo-ID-VB_2016-1.jpg
M.D., PhD, HDR
Chargée de Recherche (IRD)

UNIVERSITY EDUCATION

1993-2003       Doctor of Medicine, specialization in Public Health – University of Paris-XIII, France

2003                 Master in Public Health and Epidemiology – University of Paris-XI, School of Public Health, France

2008                 PhD in Epidemiology – University of Paris-VI, School of Public Health, France

2009-2010      Post-doc position – University of Montreal, CHU Sainte-Justine Research Center, Canada

2017                  HDR – University of Paris-V, School of Public Health, France

PAST and CURRENT POSITION

2010-2017     Chargée de Recherche – Institut de Recherche pour le Développement (IRD)

                        UMR216 « Mother and Child infection in the tropics », IRD/University of Paris Descartes, France

2017-now      Chargée de Recherche – Institut de Recherche pour le Développement (IRD)

                        IDLIC team, Inserm U1219/University of Bordeaux, France

 

Médecin épidémiologiste, Valérie Briand est Chargée de Recherche à l’Institut de Recherche pour le Développement (IRD). Elle a intégré l’équipe IDLIC en septembre 2017. Ses domaines d’expertise ciblent l’épidémiologie et la prévention du paludisme au cours de la grossesse et, de façon plus globale, la santé maternelle, périnatale et infantile en Afrique, à travers la mise en place d’essais cliniques et d’études de cohorte. Elle coordonne actuellement le programme RECIPAL, au Bénin, qui vise à évaluer l’impact du paludisme au début de la grossesse sur la croissance foetale.

Valérie Briand, MD, PhD, Chargée de Recherche de Classe 1 at IRD (Institut de Recherche pour le Développement), is a medical epidemiologist who has been working on malaria and pregnancy for more than 10 years. Since 2004, she has planned and coordinated several cross-sectional and longitudinal studies in pregnant women and children in Benin (from 2004 until present) and in Lao PDR (2013-2015). She has participated in two large clinical trials for the prevention of malaria in pregnancy by intermittent preventive treatment (IPTp), assessing mefloquine as a replacement drug for IPTp. Since 2013, she has been focusing on the maternal determinants (including malaria) of child health in Africa. She is currently coordinating a large pre-conceptional cohort study to assess the impact of malaria in early pregnancy on fetal growth in Benin (the ANR-funding RECIPAL project).

 

Complete List of Published Work in MyBibliography :  

https://www.ncbi.nlm.nih.gov/sites/myncbi/1vMyd_yJsAh/bibliography/9202637/public/?sort=date&direction=descending

Five main publications

Briand V, et al. Fetal growth restriction is associated with malaria in pregnancy: a prospective longitudinal study in Benin. J Infect Dis 2016; 214(3):417-25.

Huynh BT, et al. Burden of malaria in early pregnancy: a neglected problem? Clin Infect Dis. 2015; 60(4):598-604.

Briand V, et al. Maternal and perinatal outcomes by mode of delivery in Senegal and Mali: a cross-sectional epidemiological survey. PLoS One. 2012; 7(10):e47352.

Briand V, et al. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine. J Infect Dis. 2009 Sep 15; 200(6):991-1001.

Briand V, et al. Coinfection with Plasmodium falciparum and Schistosoma haematobium: protective effect of schistosomiasis on malaria in senegalese children? Am J Trop Med Hyg. 2005 Jun; 72(6):702-7.

logo_ISPED logo_SFR-santepublique-societe logo_CHU-Bordeaux logo_Institut-Bergonie logo_INRIA logo_ANRS logo_ARS logo_Charles-Perrens logo_IFSTTAR logo_HONcode